Electroporation in cancer treatment: The antitumor electrochemotherapy;L'électroporation dans le traitement des cancers: L'électrochimiothérapie antitumorale

Bulletin de l'Academie Veterinaire de France

Volumn 162, Issue 4, 2009, Pages 371-376

  Mir, Par Lluis M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Bleomycin; Cisplatin; Electrochemotherapy; Electroporation; Horses; Pets

Indexed keywords

EID: 84856406085     PISSN: 00014192     EISSN: 00341843     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Belehradek, J., Jr., Orlowski, S., Poddevin, B., Paoletti, C., Mir, L.M. 1991. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 27 (1): 73-76.
2. Belehradek, M., Domenge, C., Luboinski, B., Orlowski, S., Belehradek, J.Jr., Mir, L.M. 1993. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72 (12): 3694-3700.
3. Cemazar, M., Miklavcic, D., Scancar, J., Dolzan, V., Golouh, R., Sersa, G. 1999. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79 (9-10): 1386-1391.
4. Cemazar, M., Tamzali, Y., Sersa, G., Tozon, N., Mir, L.M., Miklavcic, D., Lowe, R., Teissie, J. 2008. Electrochemotherapy in veterinary oncology. J Vet Intern Med. 22 (4):826-381 (Review).
5. Gehl, J., Skovsgaard, T., Mir, L.M. 2002. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569 (1-3): 51-58.
6. Glass, L.F., Jaroszeski, M., Gilbert, R., Reintgen, D.S., Heller, R.. 1997. Intralesional bleomycinmediated electrochemotherapy in 20 patients with basal cell carcinoma. Journal of the American Academy of Dermatology 37 (4): 596-599.
7. Marty, M., Sersa, G., Garbay, J.R., Gehl, J., Collins, C., Snoj, M., Billard, V., Geertsen, P., Larkin, J., Miklavcic, D., et al. 2006. Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of the ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Supplements 4 (11):3-13.
8. Mir, L.M., Orlowski, S., Belehradek, J., Jr., Paoletti, C. 1991a. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27 (1): 68-72.
9. Mir L.M., Belehradek M., Domenge C., Orlowski, S, Poddevin, B, Belehradek, J Jr, Schwaab, G, Luboinski, B, Paoletti, C. 1991b [Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III 313 (13): 613-618.
10. Mir, L.M., Roth, C., Orlowski, S., Quintin-Colonna, F., Fradelizi, D., Belehradek J.Jr, Kourilsky, P. 1995.Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2.J. of Immunother. 17 (1): 30-38.
11. Mir, L.M., Devauchelle, P., Quintin-Colonna, F., Delisle, F., Doliger, S., Fradelizi, D., Belehradek, J Jr, Orlowski, S. 1997. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 76 (12): 1617-1622.
12. Mir, L.M., Glass, L.F., Sersa, G., Teissié, J., Domenge, C., Miklavcic, D., Jaroszeski, M.J., Orlowski, S., Reintgen, D.S., Rudolf, Z., et al. 1998. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77 (12): 2336-2342.